Affiliations

NYBA

Australia Biotech

BioMelbourne

Lab To Wall Street

Industry News

Browse news archive by:
Date | Company Name | Country/States

Dec. Nov. Oct. Sept. Aug. July
June May April March Feb. Jan.

October 2007:

October 30th:
ChemGenex Pharmaceuticals to Present at Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
read article >

October 29th:
Cytopia Announces Appointment Of New CFO And Company Secretary
read article >

October 25th:
Biosignal Initiates Oil & Gas Field Trial On Positive UK Bacterial Biofilm Results
read article >

October 23rd:
Progen Presents Preclinical Data for Second-Generation Anti-Tumor Compounds at AACR-NCI-EORTC International Conference
read article >

October 17th:
MEDEC Is Proceeding To Form MEDEC - ATOS Group
read article >

October 17th:
HealthLinx To Establish New Drug Development Company
read article >

October 17th:
Cytopia's Lead Anticancer Compound Shows Promise In Multiple Myeloma
read article >

October 12th:
Imugene Patent Protection Extended
read article >

October 8th:
ChemGenex Appoints Experienced Biotechnology Executive as Chief Medical Officer
read article >

October 8th:
US-based Promega Corp Acquires Additional Equity Stake In Benitec Ltd
read article >

October 2nd:
Dia-B Welcomes NHMRC Grant For Treatment For Diabetes Complications
read article >

October 2nd:
SteriCorp Acquires Remaining 50% Of Daniels Sharpsmart Australia For $34.6 Million
read article >

October 1st:
GTG Licenses Syngenta
read article >

  May 28th, 2009:
Arana Therapeutics Board Changes

May 6th, 2009:
Circadian Scientific Advisory Board Chairman, Professor Kari Alitalo, Wins Prestigious Award for Biomedical Research

May 5th, 2009:
Living Cell Technologies Reports Insulin Independence in Two Patients Following Recent Implants of DIABECELL® in Diabetes Clinical Trial

November 3rd:
FDA Accepts Arana's Anti-inflammatory IND

September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer

September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins

August 6th:
Xenome Strengthens Board with Two New Appointments

August 6th:
Ciba Elects to Cease Industrial Product Evaluations

June 24th:
New Pharmaxis Board Appointment

April 29th:
Benitec secures further rights to HIV Therapeutic

more industry news >
 


osullivanpllc.com  

Disclaimer